NewsRx

Search our medical news database

Migraine Headache

Drug Efficacy Is Unaffected By Menstrual Cycle In Women

Published in Women's Health Weekly, August 9th, 2001

New data show that ZomigR (zolmitriptan), produced by AstraZeneca (AZN), is effective in treating migraine regardless of its relationship to menses.

The data were released at the American Headache Society Meeting in New York City, New York, on June 30, 2001. Sixty percent of women who are migraine sufferers experience migraine during, or right after, their menstrual cycles.

"There is a perception that migraine attacks related to menses are more severe and resistant to acute treatment than those unrelated to menses, but there is little existing clinical data to support this," said Susan Abu-Shakra, MD, AstraZeneca. "However, these...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook